2025-12-31 - Analysis Report
Okay, here's a breakdown of Salesforce (CRM) based on the provided data, with simple numbers first, followed by analysis:

**0) Overview:**

*   **Ticker:** CRM
*   **Company:** Salesforce Inc.
*   **Company Overview:** Salesforce Inc. is a cloud-based software company providing customer relationship management (CRM) services.

**1) Return Rate Comparison (CRM vs. VOO):**

*   **CRM Cumulative Return:** -1.89%
*   **VOO (S&P 500) Cumulative Return:** 102.21%
*   **Divergence:** -105.0 (Current); Range: -116.9 (Min) to 54.1 (Max); Relative Divergence: 7.0
*   **Analysis:** CRM has significantly underperformed the S&P 500 (VOO). The divergence is substantial. The relative divergence of 7.0 suggests the current divergence is near the minimum observed in the historical data range, indicating potential for improvement if historical patterns hold.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | 39.0%   | 70.6%   | 10.0%   | -0.0   | 97.3   |
| 2016-2018  | 34.0%   | 73.5%   | 19.0%   | 0.1    | 130.4  |
| 2017-2019  | 22.0%   | 73.5%   | 0.0%    | 0.4    | 154.8  |
| 2018-2020  | 14.0%   | 73.5%   | -10.0%  | 0.4    | 211.8  |
| 2019-2021  | 37.0%   | 71.9%   | -10.0%  | 0.7    | 241.9  |
| 2020-2022  | -78.0%  | 74.7%   | -78.0%  | 0.4    | 126.2  |
| 2021-2023  | -47.0%  | 76.6%   | -49.0%  | -0.6   | 250.5  |
| 2022-2024  | -42.0%  | 76.6%   | -63.0%  | -0.4   | 318.3  |
| 2023-2025  | 9.0%    | 76.6%   | -57.0%  | -2.1   | 253.2  |

*   **CAGR:** Fluctuating CAGR, with significant negative values in recent years, indicates volatile growth.
*   **MDD:** High Maximum Drawdown (MDD) values consistently above 70% suggest substantial risk and price volatility.
*   **Alpha:** The negative Alpha values in recent periods indicate CRM has underperformed relative to its benchmark.
*   **Beta:** The Beta values vary, with a significant negative shift recently, indicating a changing correlation with the market.
*   **Cap:** Market capitalization shows growth over time, although it has fluctuated, reflecting market sentiment and performance.

**2) Stock Price Fluctuations:**

*   **Current Price:** 265.92
*   **Previous Close:** 266.23
*   **Price Change:** -0.12
*   **5-day SMA:** 265.384
*   **20-day SMA:** 259.0656
*   **60-day SMA:** 248.8942
*   **Analysis:** The 5-day SMA is slightly above the 20-day SMA, and both are above the 60-day SMA, suggesting a short-term upward trend. The small price change indicates minimal recent movement.

**3) Indicators Analysis:**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment)
*   **RSI:** 58.83 (Neutral â€“ neither overbought nor oversold)
*   **PPO:** 0.1863
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-02)
*   **Recent Divergence Change:** -0.5 (Negative - Short-term Decline)
*   **Expected Return:** -643.5% (Very Poor)
*   **Analysis:** The MRI suggests medium investment risk. The RSI is neutral. The hybrid signal recommends buying, albeit cautiously. The negative divergence change indicates a recent short-term decline. The Expected Return is extremely negative, which is a major red flag.

**4) Recent News & Significant Events:**

*   **Themes:** The news headlines are mixed.
    *   Some articles discuss whether CRM is a buy now or highlight positive earnings news potentially ending a losing streak.
    *   Others focus on price predictions for 2026-2030 and potential buy signals.
    *   One article notes CRM being labeled as an "AI Loser" but suggests this label may be about to vanish.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.64)
*   **Opinions:** 53
*   **Target Price:** Avg: 330.06 / High: 475.00 / Low: 223.00
*   **Analysis:** Analysts generally have a "Buy" rating on CRM. The average target price suggests potential upside from the current price, but a wide range between high and low targets indicates uncertainty. No recent rating changes were provided, so no conclusion can be made about the direction of analyst sentiment.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-12-04 | 2.2  | 10.26 B$    |
| 2025-09-04 | 1.97 | 10.24 B$    |
| 2025-05-29 | 1.61 | 9.83 B$    |
| 2024-12-04 | 1.6  | 9.44 B$    |
| 2025-12-04 | 1.6  | 9.44 B$    |

*   **Trend:** Both EPS and Revenue show a generally upward trend. The most recent EPS figure is significantly higher than previous values.
*   **Analysis:** The rising EPS and revenue figures suggest improving financial performance.

**6) Financial Information:**

Revenue and Profitability:

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|----------------|
| 2025-10-31 | $10.26B  | 78.02%        |
| 2025-07-31 | $10.24B  | 78.10%        |
| 2025-04-30 | $9.83B   | 76.96%        |
| 2025-01-31 | $9.99B   | 77.81%        |
| 2024-10-31 | $9.44B   | 77.71%        |

Capital and Profitability:

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-10-31 | $60.02B  | 3.48% |
| 2025-07-31 | $61.33B  | 3.08% |
| 2025-04-30 | $60.67B  | 2.54% |
| 2025-01-31 | $61.17B  | 2.79% |
| 2024-10-31 | $58.52B  | 2.61% |

*   **Revenue:** Revenue shows a generally upward trend.
*   **Profit Margin:** Profit margins are consistently high.
*   **Equity:** Equity is relatively stable.
*   **ROE:** Return on Equity (ROE) fluctuates, with the most recent quarter showing a higher value.
*   **Analysis:** The data suggests strong revenue growth and profitability. The increasing ROE in the latest quarter is a positive sign.

**7) Comprehensive Analysis:**

*   **Negative Performance vs. S&P 500:** CRM has significantly underperformed the S&P 500.
*   **Volatile Historical Performance:** CRM has experienced high volatility and significant drawdowns.
*   **Recent Improved Financials:** Recent earnings and financial data indicate improving revenue, EPS, and ROE.
*   **Mixed Sentiment:** Analyst sentiment is generally positive, but news headlines reflect some uncertainty, especially regarding CRM's position in the AI space.
*   **Conflicting Signals:** The MRI indicates medium risk, but the extremely negative expected return is a serious concern. The recommendation to buy is potentially premature in light of CRM's significant underperformance versus the market and the fact that the expected return from this point is so heavily negative.

**Conclusion:**

CRM presents a mixed picture. While recent financial performance shows improvement, and analysts are generally positive, the stock has significantly underperformed the market. The extremely negative expected return is a major cause for concern and requires further investigation to understand the underlying factors contributing to this pessimistic outlook. Investors should proceed with caution and conduct thorough due diligence before considering an investment in CRM.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.